T2-high asthma is seen in around 50% of patients, who typically have eosinophilic inflammation mediated by cytokines including IL-4, IL-5, and IL-13, with enhanced levels of immunoglobulin E (IgE) often present. This evidence concerns the gene IL4 and asthma.